Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Wang, X. Haeussler, K. Spellman, A. Phillips, L. E. Ramiller, A. Bausch-Jurken, M. T. Sharma, P. Krivelyova, A. Vats, S. Van de Velde, N.

Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Hossaini, S. Keramat, F. Cheraghi, Z. Zareie, B. Doosti-Irani, A.

Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Kuziez, L. Eleiwa, T. K. Chauhan, M. Z. Sallam, A. B. Elhusseiny, A. M. Saeed, H. N.

Corneal Adverse Events Associated with SARS-CoV-2/COVID-19 Vaccination: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Teferi, G. Kefale, B.

Coronavirus vaccine acceptance in Ethiopia: Systematic review and meta-analysis

  • Africa
  • Ethiopia
  • All age groups
  • Healthcare workers
  • Pregnant women
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Zhou, Q. Liu, Y. Zeng, F. Meng, Y. Liu, H. Deng, G.

Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ He, Y. F. Ouyang, J. Hu, X. D. Wu, N. Jiang, Z. G. Bian, N. Wang, J.

Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Fu, Y. Zhao, J. Han, P. Zhang, J. Wang, Q. Wang, Q. Wei, X. Yang, L. Ren, T. Zhan, S. Li, L.

Cost-effectiveness of COVID-19 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Sidhu, N. Vanathi, M. Gupta, N. Tandon, R.

COVID and COVID vaccine-related corneal morbidity: A review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Agustin, M. Trifitriana, M. Danarti, R.

COVID arm as a common cutaneous manifestation after mRNA-1273 vaccination: a systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Bianchi, F. P. Donghia, R. Tatoli, R. Bonfiglio, C.

COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis

  • Adults
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...